Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic radiation therapy with unsealed radionuclides.

I R McDougall1

  • 1Division of Nuclear Medicine, Stanford University Medical Center, Stanford, CA 94305, USA.

Seminars in Radiation Oncology
|March 23, 2000
PubMed
Summary

Systemic unsealed radiation therapy uses radioactive substances to target abnormal tissues, primarily for hyperthyroidism and thyroid cancer. This targeted approach minimizes radiation exposure to healthy organs, offering a well-tolerated treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.

Molecular imaging and biology·2006
Same author

Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?

Molecular imaging and biology·2006
Same author

Long-term results of irradiation for patients with progressive Graves' ophthalmopathy.

International journal of radiation oncology, biology, physics·2001
Same author

Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Same author

Thyroid carcinoma after successful treatment of osteosarcoma: a report of three patients.

Journal of pediatric hematology/oncology·2001
Same author

Positron emission tomography of the thyroid, with an emphasis on thyroid cancer.

Nuclear medicine communications·2001

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Endocrinology

Background:

  • Systemic unsealed radiation therapy involves administering radioactive substances that concentrate in specific organs.
  • This method delivers a therapeutic radiation dose locally to abnormal tissues.
  • Normal organs not accumulating the radioactive material receive minimal radiation exposure.

Purpose of the Study:

  • To summarize the principles and applications of systemic unsealed radiation therapy.
  • To highlight common uses such as treating hyperthyroidism and differentiated thyroid cancer.
  • To discuss other therapeutic applications and the general safety profile of these treatments.

Main Methods:

  • Administration of radioactive substances (radiopharmaceuticals) orally or parenterally.

Related Experiment Videos

  • Utilizing radioactive materials that emit beta particles for targeted radiation delivery.
  • Focusing on organs or sites with high uptake of the radiopharmaceutical.

    • Main Results:

    • Effective treatment for hyperthyroidism and differentiated thyroid cancer using radioiodine (131)I.
    • Successful application in managing painful skeletal metastases, polycythemia vera, malignant cysts, and neuroendocrine tumors.
    • Treatments are generally well-tolerated with minimal long-term adverse effects like secondary cancers or infertility.

    Conclusions:

    • Systemic unsealed radiation therapy provides targeted internal radiation for various conditions.
    • It offers a favorable risk-benefit profile, particularly for endocrine and oncologic applications.
    • The localized nature of radiation delivery ensures safety for non-target tissues.